GLP-1 'hidden risks' claims on TikTok: what holds up?

What did @holisticlifebymia actually say?

Straightforwardly: nothing about GLP-1 medications. The entire transcript is a set of Taylor Swift lyrics, likely from a trending audio clip overlaid on what appears to be health-related video content. There are no medical claims here, no risk warnings, and no actual discussion of Ozempic, semaglutide, or any GLP-1 receptor agonist.

The caption promises to expose "hidden risks" and warns viewers to "think again" before trying something, but the spoken content delivers zero health information. What you actually get is: "When you are young, they assume you know nothing" and imagery about Peter Pan and waterlines. That is not a risk disclosure. That is a song.

This matters because the framing, the hashtags (#ozempic, #guthealth, #weightloss), and the alarming caption are doing real persuasive work on viewers who may be making decisions about their own care, while the actual audio contributes nothing clinically useful.

Does the science back this up?

There is no medical claim to evaluate here. But since the caption raises the question of GLP-1 risks, and viewers may have come looking for answers, it is worth being direct about what the actual evidence says on that topic.

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) do carry real, documented risks. These are not hidden. The FDA label and published trial data are public. Common adverse effects include nausea, vomiting, diarrhea, and constipation, reported in 30 to 50 percent of patients in SURMOUNT-1 (Jastreboff et al., 2022, New England Journal of Medicine) and STEP 1 (Wilding et al., 2021, NEJM). More serious signals include a black-box warning for thyroid C-cell tumors in rodent studies, though causation in humans has not been established. Acute pancreatitis is a rare but documented risk.

So yes, there are legitimate things to know before starting a GLP-1. This video just does not tell you any of them.

What did they get wrong (or right)?

The creator got the caption framing mostly right in spirit: GLP-1 medications are genuinely not appropriate for everyone. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. They require caution in patients with a history of pancreatitis or severe gastrointestinal disease.

But the video itself got everything wrong by delivering none of this. The mismatch between the alarming promise of the caption and the total absence of medical content in the audio is, charitably, a content production error. Less charitably, it is engagement bait using health anxiety as a hook with no informational payoff.

The lyric "when you are young, they assume you know nothing" is ironically apt here. Viewers seeking information about GLP-1 risks deserve to be treated like adults who can handle actual data, not algorithmic packaging with no substance inside.

What should you actually know?

If you found this video because you are weighing whether a GLP-1 medication is right for you, here is what the evidence actually supports.

• GLP-1 receptor agonists are FDA-approved for type 2 diabetes management and, at higher doses, for chronic weight management in adults with obesity or overweight with a weight-related comorbidity.
• They are not appropriate for everyone. A licensed provider needs to review your medical history, including thyroid history, gastrointestinal conditions, and current medications, before prescribing.
• Side effects are common and often dose-dependent. Slowing the titration schedule significantly reduces discontinuation rates, per Davies et al. (2021, Diabetes Care).
• Compounded semaglutide is not the same as FDA-approved Ozempic or Wegovy. Formulation, excipients, and quality controls differ, and the FDA has issued warnings about compounded versions.
• Stopping a GLP-1 without a plan is associated with weight regain. Knop et al. (2022, NEJM) found most participants regained two-thirds of lost weight within one year of stopping semaglutide.

If a TikTok video's entire health content is song lyrics, that is a signal to go find a better source before making any decisions about your care.